In patients with ARDS, sFasL was detectable in the lung before and after the onset of clinically defined ARDS, and nonsurvivors had significantly higher BAL levels of sFasL on day 1 as compared with survivors [200]. The gene discussed is FASLG; the disease is acute respiratory distress syndrome.